Khandwala M, Ahmed S, Goel S, Simmons I G, McLure H A
Department of Ophthalmology, St James's University Hospital, Beckett Street, Leeds, UK.
Eye (Lond). 2008 Aug;22(8):1065-8. doi: 10.1038/sj.eye.6702860. Epub 2007 May 25.
To determine by B-scan ultrasonography if the addition of hyaluronidase affects the dispersal of anaesthetic fluid after sub-Tenon's injection.
Single-centre prospective randomised double-blind study.
We performed a trial in 19 patients who were randomised to receive 5 ml of lidocaine 2% alone, or with hyaluronidase 15 IU/ml. A pre-anaesthetic B-scan ultrasound was performed followed by a standard infero-nasal sub-Tenon's injection. Further B-scan ultrasound studies were performed at 1, 3, and 5 min recording depth of local anaesthetic fluid. Data was analysed with Fisher's exact test and Student's t-test where appropriate. Results were considered significant when P<0.05.
The maximum depth of local anaesthetic was significantly less in the hyaluronidase group than the control group at 3 and 5 min (0.79 vs1.65 mm, P-value 0.01 and 0.43 vs1.52 mm, P-value 0.002 respectively). There were no statistically significant differences in the akinesia, pain and surgical satisfaction scores between the two groups.
The addition of hyaluronidase significantly augments the dispersal of local anaesthetic fluid, as measured by B-scan ultrasonography.
通过B超检查确定在球后注射麻醉药时添加透明质酸酶是否会影响麻醉药的扩散。
单中心前瞻性随机双盲研究。
我们对19例患者进行了试验,将其随机分为两组,一组单独接受5毫升2%利多卡因,另一组接受含15国际单位/毫升透明质酸酶的5毫升2%利多卡因。麻醉前进行B超检查,然后进行标准的鼻下球后注射。在注射后1分钟、3分钟和5分钟进行进一步的B超检查,记录局部麻醉药的深度。数据在适当情况下采用Fisher精确检验和学生t检验进行分析。当P<0.05时,结果被认为具有统计学意义。
在3分钟和5分钟时,透明质酸酶组局部麻醉药的最大深度显著低于对照组(分别为0.79毫米对1.65毫米,P值为0.01;0.43毫米对1.52毫米,P值为0.002)。两组之间的运动不能、疼痛和手术满意度评分无统计学显著差异。
通过B超检查测量,添加透明质酸酶可显著增强局部麻醉药的扩散。